Editorial Volume 8, Issue 9 pp 1830—1831

Bcl-xL inhibition - a novel strategy for glioma therapy

Georg Karpel-Massler^1,2, , Markus D. Siegelin^1, ,

¹ Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA
² Department of Neurosurgery, Ulm University Medical Center, Ulm, Germany

Received: September 21, 2016 Published: September 28, 2016

https://doi.org/10.18632/aging.101074
How to Cite